📢 Liquid biopsy for pancreatic cancer: findings & challenges in the overseas scenario🧬

📅 April 23, 2026
⏰ 14:00–15:00 (CET)
💻 More here: transpan.eu/transpan-web...

Join us to explore new insights in pancreatic cancer research and the global challenges of liquid biopsy 🌍🔬

#LiquidBiopsy

📢 We are #hiring!

▫️Group Leader Chemical Biology
▫️Group Leader Structural Biology
▫️Section Head, International Promotion
▫️ Public Procurement Officer (Maternity leave)
▫️Purchasing Technician (temporary)

...and more!

 ➡️ https://bit.ly/irbjobs

#IRBJobs #ScienceJobs #JobOffer #OncoSky #AcademicSky

Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives Pancreatic cancer remains one of the most lethal malignancies, largely due to late diagnosis, marked tumor heterogeneity, and profound resistance to t…

Ever wondered what non-coding RNAs do in pancreatic ductal adenocarcinoma (PDAC)? 🧬🔬

In this review, we summarize a fast-moving field 🚀 with real translational potential 💡 in PDAC research—and what it could mean for future therapies 💊

Read here 📑: www.sciencedirect.com/science/arti...

📢 New workshop coming soon!

Bridging Basic and Clinical Research in Pancreatic Cancer Biomarkers 🌟

🗓 June 19, 2026
📍 Olomouc, Czech Republic

🔬 Organized by Prof. Beatrice Mohelníková Duchoňová

🔗 Register here:
forms.cloud.microsoft/Pages/Respon...

ℹ️ More info:
transpan.eu/event/transp...

Happy to amplify this 💜 Supporting research, scientists, and patient-centered initiatives is crucial to advancing pancreatic cancer outcomes.

A beautiful gesture 💜 Supporting pancreatic cancer research is crucial to improving outcomes. Thank you for being part of this effort!

Thanks for sharing! Really interesting to see progress on KRAS p.G12D, especially given how common it is in pancreatic cancer.
Hope more trials coming soon!

𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐧𝐠 𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐢𝐜 𝐜𝐚𝐧𝐜𝐞𝐫 𝐢𝐧 𝐡𝐢𝐠𝐡-𝐫𝐢𝐬𝐤 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥𝐬 𝐚𝐧𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐞𝐧𝐞𝐫𝐚𝐥 𝐩𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧: 𝐡𝐨𝐰 𝐥𝐨𝐧𝐠 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐨𝐚𝐝 𝐲𝐞𝐭? 🧬

📍 Pisa, Italy 🍕
📅 Friday, June 5, 2026

📝 𝐇𝐨𝐰 𝐭𝐨 𝐚𝐩𝐩𝐥𝐲
transpan.eu/event/worksh...

📅 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: April 10, 2026
Deadline approaching, we look forward to receiving your applications! ✨

Genetics and biological processes can strongly influence cancer development.
This week we explain:
• Hereditary #pancreaticcancer syndromes
• KRAS mutations
• Inflammation

These concepts help researchers understand why certain cancers develop and how they progress.
#CancerBiology #Genetics

Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC) - PubMed The risk-stratified group (FR) identifies neoplastic pancreatic lesion in individuals, regardless of PV status suggesting the key usefulness of this approach.

🚨 New publication 🧬

Risk-stratified surveillance improves detection of actionable pancreatic lesions in high-risk individuals at an early, operable stage:
pubmed.ncbi.nlm.nih.gov/41740463/

👏 Great to see TRANSPAN members contributing to this important work.

#PancreaticCancer #Surveillance #Hope

Read more here: transpan.eu/the-fourth-p...

Last week, the TRANSPAN Annual Meeting was successfully held in Athens🎉

A key dialogue highlight reminding us why we do this work:
“What can we do more and better for patients? What can patients do to help us?”💜

#PancreaticCancer #Research #Collaboration #Hope #Oncology #Genetics #MolecularBiology

Upcoming webinar today at 14.00 CET time! 💥

"Liquid Biopsy Diagnostics for Perioperative Care in PDAC - Insights from an East German Academic Surgery Department" 🧪 🧬

Join us and discover the value of liquid biopsy at the frontier of research in pancreatic cancer! 💫

transpan.eu/transpan-web...

Time is running out! Join our Training School "In Vitro & In Vivo Models for Functional Genomics" in Bratislava! 🧬

Financial support will be provided to selected participants. 🌟

Want to know more? Get in touch!

#PancreaticCancer #YoungResearchers #Collaboration #Hope #Networking #Science

🧬 Applications open!✨🔥
COST TRANSPAN Training School: In Vitro & In Vivo Models for Functional Genomics

📍 Bratislava
📅 18–20 May 2026

🔥🔥Read the proposed agenda: docs.google.com/document/d/1....

📄 Apply by 22 Mar 2026 (CV + motivation letter) here:
docs.google.com/forms/d/e/1F...

Get in touch!

🎉 Excited for the TRANSPAN Final General Meeting in Athens 🇬🇷 on Mar 19–20!

Two days of meetings, celebrating achievements, outputs & collaborations in pancreatic cancer research 🧬💡

Will you be there? Don't miss this incredible opportunity!

transpan.eu/event/fourth...

#Research#Athens2026#Hope

🌟 In TRANSPAN, the 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐚𝐲 𝐨𝐟 𝐖𝐨𝐦𝐞𝐧 𝐢𝐧 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 doesn't last one day. What are you waiting for? Join us!🌟

👩‍🔬𝐃𝐫. Julie Earl, 𝐏𝐡𝐃, will lead our 𝐖𝐞𝐛𝐢𝐧𝐚𝐫:
“𝐓𝐡𝐞 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲: 𝐀 𝐑𝐨𝐚𝐝𝐦𝐚𝐩 𝐟𝐨𝐫 𝐄𝐚𝐫𝐥𝐲 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞 𝐢𝐧 𝐏𝐃𝐀𝐂” 🧬💉
🔗 𝐅𝐞𝐛 𝟏𝟗𝐭𝐡 at 𝟏𝟒:𝟎𝟎 CET! 📆
#Research#Women

🧠 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞… 𝐛𝐮𝐭 𝐧𝐨𝐭 𝐬𝐮𝐫𝐞 𝐰𝐡𝐨 𝐡𝐚𝐬 𝐢𝐭?
🧪 𝐍𝐞𝐞𝐝 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐬𝐚𝐦𝐩𝐥𝐞𝐬 𝐨𝐫 𝐨𝐦𝐢𝐜𝐬 𝐝𝐚𝐭𝐚?
🤝 𝐖𝐨𝐧𝐝𝐞𝐫𝐢𝐧𝐠 𝐰𝐡𝐨 𝐭𝐨 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 𝐭𝐨 𝐬𝐭𝐚𝐫𝐭 𝐧𝐞𝐰 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧s?

✨𝐓𝐑𝐀𝐍𝐒𝐏𝐀𝐍 𝐖𝐡𝐨’𝐬 𝐖𝐡𝐨 is a searchable overview of the research groups within TRANSPAN, designed to make connections easier and collaborations faster:

Join conversation

🧬 Cell Competition in the Adult Pancreas
How cells fight for survival - and how cancer may begin.

🎤 Dr. Catherine Hogan, PhD (ECSCRI)
Cardiff University, UK
📅22.01.2026 2-3 pm CET time

✨ Women in science (and in TRANSPAN) don’t just belong - they lead.

#CancerResearch #PublicScience #STEMEquality

✨ A new year, a new chapter for TRANSPAN✨
All the results obtained so far will be published starting from last year’s work.
👉 Follow us and stay tuned: many ambitious, exciting updates are coming this year 🚀🔬

#NewYear #ScienceUpdates #PancreaticCancer#Research #Collaboration#OpenScience #Innovation

Join conversation

Have you ever heard about the pancreatic cancer microbiome and its effect?💡🔬

Let us introduce the new "Pancreatic cancer microbiome: Signal or Noise?" webinar!

🎤 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: Prof. Albrecht Neesse, MD, PhD
📅 𝗗𝗮𝘁𝗲 𝗮𝗻𝗱 𝗧𝗶𝗺𝗲: 20.11.2025, 14-15 CET
💻 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Online

teams.microsoft.com/dl/launcher/...

💜 World Pancreatic Cancer Day 20.22.2025 💜

At TRANSPAN, we’re turning awareness into real action.
This month on our site:
🎯 Early-signs awareness
🎓 Expert talks
💡 Prevention resources
🤝 Community support

Let’s choose knowledge, responsibility, and care. 💜

🔗 transpan.eu

#Awareness #Hope #Cancer

Tomorrow is THE day! Don't miss this exceptional opportunity!

#Research #Collaboration #Science #Omics #Hope #Cure #Investigation #CancerFree

💜 Every breakthrough counts.

Join us for a webinar on how omics data is transforming pancreatic cancer research, and why dataset size truly matters in driving discoveries.

🗓 October 23
🕑 2 PM CET
💻 Microsoft Teams: tinyurl.com/ym94cbt3

#Research #Hope #Science #Collaboration

🔬 Upcoming TRANSPAN Webinar!

💬 Modeling Pancreatic Cancer Risk with Omics Data – Why Size Matters

🗓 Oct 23, 2025
🕑 14:00 CET
💻 Online

Discover how large-scale omics are reshaping our understanding of pancreatic cancer and why size is a key!

More info coming soon!

#TRANSPAN #PancreaticCancer

🌍🔬 Meet Transpan!

We are the largest European network uniting researchers from every biomedical background with one shared goal: advancing the understanding and treatment of pancreatic cancer.

👉 Join us to accelerate discoveries and improve patient outcomes. 💡💙

transpan.eu

#PancreaticCancer

Take the chance and join our upcoming webinar on pancreatic cancer epidemiology!

🔗 Join here: teams.microsoft.com/dl/launcher/...

Don’t miss this opportunity to explore the latest insights from a leading expert!

#PancreaticCancer #Epidemiology #Research #CollaborativeEfforts #Cancer #Hope #COST

🚨 Save the Date! 🚨

Next TRANSPAN Webinar 🎙️
📅 Sept 18, 2025, 14:00 CEST
🌐 Online: lnkd.in/dt24zxkw

Topic: Pancreatic Cancer Epidemiology 🧬
Speaker: Verena Katzke, PhD (DKFZ 🇩🇪)

Get into the epidemiology of pancreatic cancer with leading experts in the field!

Don’t miss it! More info 👉 transpan.eu

Therapeutic pancreatic cancer biomarkers and pharmacogenetics FOLFIRINOX and gemcitabine plus nab-paclitaxel represent the most effective chemotherapy regimens for metastatic pancreatic cancer patients nowadays, …

❓Why do some pancreatic cancer patients respond to therapy, while others don’t?

Our new review dives into 🧬 biomarkers & pharmacogenetics in FOLFIRINOX, gem/nab-paclitaxel & more. The future is precision therapy.

👉 www.sciencedirect.com/science/arti...

#PancreaticCancer #PrecisionOncology

We’re back from summer break ☀️, and so is the 𝐓𝐑𝐀𝐍𝐒𝐏𝐀𝐍 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐒𝐞𝐫𝐢𝐞𝐬! 🎙️

Next up:
📅 18 Sept - 𝘗𝘢𝘯𝘤𝘳𝘦𝘢𝘵𝘪𝘤 𝘊𝘢𝘯𝘤𝘦𝘳 𝘌𝘱𝘪𝘥𝘦𝘮𝘪𝘰𝘭𝘰𝘨𝘺 w/ Dr Verena Katzke (DKFZ)

Join us and connect with leading experts in pancreatic cancer research.

👉 Additional info coming soon!

#PancreaticCancer #Epidemiology #Science